Home Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development By - March 15, 2024 39 0 Facebook Twitter Pinterest WhatsApp The Israel-based company is the result of AION Labs’ fifth startup challenge. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Video game therapeutic developer Akili Interactive to go public via SPAC Pilots - January 26, 2022 0 Immersive tech company FourPlus secures funds to create mixed reality platform Pilots - July 10, 2023 0 HealthCare.com scores additional $31.5M and more digital health fundings Pilots - February 8, 2022 0 Google Health licenses breast cancer screening AI to iCAD Pilots - November 28, 2022 0 Fujitsu begins research to develop AI for early pancreatic cancer detection in Japan Pilots - May 3, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3